Aspo Oyj Just Beat EPS By 31%: Here's What Analysts Think Will Happen Next

It's been a good week for Aspo Oyj (HEL:ASPO) shareholders, because the company has just released its latest third-quarter results, and the shares gained 9.4% to €6.76. It looks to have been a decent result overall - while revenue fell marginally short of analyst estimates at €144m, statutory earnings beat expectations by a notable 31%, coming in at €0.17 per share. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

After the latest results, the three analysts covering Aspo Oyj are now predicting revenues of €562.1m in 2026. If met, this would reflect a notable 9.5% improvement in revenue compared to the last 12 months. Per-share earnings are expected to bounce 152% to €1.11. Yet prior to the latest earnings, the analysts had been anticipated revenues of €575.7m and earnings per share (EPS) of €1.05 in 2026. So it's pretty clear that while sentiment around revenues has declined following the latest results, the analysts are now more bullish on the company's earnings power.

Check out our latest analysis for Aspo Oyj

There's been no real change to the average price target of €6.80, with the lower revenue and higher earnings forecasts not expected to meaningfully impact the company's valuation over a longer timeframe. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. There are some variant perceptions on Aspo Oyj, with the most bullish analyst valuing it at €7.10 and the most bearish at €6.50 per share. The narrow spread of estimates could suggest that the business' future is relatively easy to value, or thatthe analysts have a strong view on its prospects.

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. The analysts are definitely expecting Aspo Oyj's growth to accelerate, with the forecast 7.5% annualised growth to the end of 2026 ranking favourably alongside historical growth of 2.8% per annum over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 6.0% annually. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Aspo Oyj to grow faster than the wider industry.

The Bottom Line

The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around Aspo Oyj's earnings potential next year. Regrettably, they also downgraded their revenue estimates, but the latest forecasts still imply the business will grow faster than the wider industry. Still, earnings per share are more important to value creation for shareholders. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that in mind, we wouldn't be too quick to come to a conclusion on Aspo Oyj. Long-term earnings power is much more important than next year's profits. At Simply Wall St, we have a full range of analyst estimates for Aspo Oyj going out to 2027, and you can see them free on our platform here..

However, before you get too enthused, we've discovered 2 warning signs for Aspo Oyj (1 is potentially serious!) that you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.